Below are the most recent publications written about "Tobacco Use Disorder" by people in Profiles.
-
Schnoll RA, Leone FT, Quinn MH, Stevens N, Flitter A, Wileyto P, Kimberly J, Beidas RS, Hatzell J, Siegel SD, Crawford G, Hill N, Deatley T, Ziedonis D. A randomized clinical trial testing two implementation strategies to promote the treatment of tobacco dependence in community mental healthcare. Drug Alcohol Depend. 2023 06 01; 247:109873.
-
Siegel SD, Laurenceau JP, Hill N, Bauer AM, Flitter A, Ziedonis D, Stevens N, Hosie Quinn M, Leone F, Beidas R, Kimberly J, Schnoll RA. Assessing barriers to providing tobacco use disorder treatment in community mental health settings with a revised version of the Smoking Knowledge, Attitudes, and Practices (S-KAP) instrument. Addict Behav. 2021 03; 114:106735.
-
Quintanilla ME, Ezquer F, Morales P, Santapau D, Berr?os-C?rcamo P, Ezquer M, Herrera-Marschitz M, Israel Y. Intranasal mesenchymal stem cell secretome administration markedly inhibits alcohol and nicotine self-administration and blocks relapse-intake: mechanism and translational options. Stem Cell Res Ther. 2019 07 08; 10(1):205.
-
Patterson F, Grandner MA, Malone SK, Rizzo A, Davey A, Edwards DG. Sleep as a Target for Optimized Response to Smoking Cessation Treatment. Nicotine Tob Res. 2019 01 04; 21(2):139-148.
-
Hirvonen J, Zanotti-Fregonara P, Gorelick DA, Lyoo CH, Rallis-Frutos D, Morse C, Zoghbi SS, Pike VW, Volkow ND, Huestis MA, Innis RB. Decreased Cannabinoid CB1 Receptors in Male Tobacco Smokers Examined With Positron Emission Tomography. Biol Psychiatry. 2018 11 15; 84(10):715-721.
-
Kuwabara H, Heishman SJ, Brasic JR, Contoreggi C, Cascella N, Mackowick KM, Taylor R, Rousset O, Willis W, Huestis MA, Concheiro M, Wand G, Wong DF, Volkow ND. Mu Opioid Receptor Binding Correlates with Nicotine Dependence and Reward in Smokers. PLoS One. 2014; 9(12):e113694.
-
Rose EJ, Ross TJ, Salmeron BJ, Lee M, Shakleya DM, Huestis MA, Stein EA. Acute nicotine differentially impacts anticipatory valence- and magnitude-related striatal activity. Biol Psychiatry. 2013 Feb 01; 73(3):280-8.
-
Rose EJ, Ross TJ, Salmeron BJ, Lee M, Shakleya DM, Huestis M, Stein EA. Chronic exposure to nicotine is associated with reduced reward-related activity in the striatum but not the midbrain. Biol Psychiatry. 2012 Feb 01; 71(3):206-13.
-
Doyle GA, Wang MJ, Chou AD, Oleynick JU, Arnold SE, Buono RJ, Ferraro TN, Berrettini WH. In vitro and ex vivo analysis of CHRNA3 and CHRNA5 haplotype expression. PLoS One. 2011; 6(8):e23373.
-
Donovan DM, Bigelow GE, Brigham GS, Carroll KM, Cohen AJ, Gardin JG, Hamilton JA, Huestis MA, Hughes JR, Lindblad R, Marlatt GA, Preston KL, Selzer JA, Somoza EC, Wakim PG, Wells EA. Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction. 2012 Apr; 107(4):694-708.